Pay in 4 interest-free payments of $7.47 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
On December 19, 2025, Eli Lilly announced that retatrutide produced 28.7% body weight loss in the Phase 3 TRIUMPH-4 trial
"After just a few days, all of the pigment-regenerating stem cells were lost
The article suggests these may correlate with how someone responds early and how soon a provider revisits the plan, though it cites no studies for those associations
Targeted delivery of low-dose dexamethasone using PCL-PEG micelles for effective treatment of rheumatoid arthritis
Morgan cut to $35, flagging deceptive marketing as a blow to Hims brand and predicting regulatory scrutiny
This contraindication stems from observations in rodent studies where tirzepatide and similar GLP-1 receptor agonists caused thyroid C-cell tumors at clinically relevant exposures
US$ 29.30
US$ 28.96
US$ 27.31
US$ 22.40
US$ 27.99
